GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹-8.59 Cr | ₹-13 Cr | ₹-14 Cr | ₹-5.16 Cr |
What is the latest Cash Flow from Financing Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹-8.59 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹-14 Cr |
| Mar2021 | ₹-5.16 Cr |
How is Cash Flow from Financing Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | Positive | |
| Mar2024 | ₹-8.59 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹-14 Cr | Negative | |
| Mar2021 | ₹-5.16 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,151.8 Cr | 8% | 7.2% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 8% |
7.2% |
3.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses